Sylvie D Freeman (Sylvie Freeman, Nicholas McCarthy)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 41

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia

Ejection Fraction

Tyrosine Kinase

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Jurjen Versluis, Marlen Metzner, Ariel Wang, Patrycja Gradowska, Abin Thomas, Niels Asger Jakobsen, Alison Kennedy, Rachel Moore, Emma Boertjes, Christian M Vonk, Francois G Kavelaars, Melissa Rijken, Amanda Gilkes, Claire Schwab, H Berna Beverloo, Markus Gabriel Manz, Otto Visser, Catharina H M J Van Elssen, Okke de Weerdt, Lidwine W Tick, Bart J Biemond, Marie-Christiane Vekemans, Sylvie D Freeman, Christine J Harrison, Jonathan Alistair Cook, Mike Dennis, Stephen Knapper, Ian Thomas, Charles F Craddock, Gert J Ossenkoppele, Bob Löwenberg, Nigel H Russell, Peter J M Valk, Paresh Vyas
Risk Stratification in Older Intensively Treated Patients With AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Frances Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, James Durrell Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan K Burnett, Charlotte S Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Post induction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Nicholas McCarthy, Gege Gui, Florent Dumezy, Christophe Roumier, Georgia Andrew, Sarah Green, Madeleine Jenkins, Alexandra C Adams, Naeem Khan, Charles F Craddock, Christopher S Hourigan, Adriana Plesa, Sylvie D Freeman
Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance. Leukemia 38 (8) (2024)
Jad Othman, Nicola Potter, Adam Ivey, Yanis Tazi, Elli Papaemmanuil, Jelena Jovanovic, Sylvie D Freeman, Amanda Frances Gilkes, Rosemary E Gale, Tanya Rapoz-D'Silva, Manohursingh Runglall, Michelle Kleeman, Pawan Dhami, Ian Thomas, Sean J Johnson, Joanna Canham, James Durrell Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Kenneth Burnett, Charlotte S Wilhelm-Benartzi, Brian James Patrick Huntly, Nigel H Russell, Richard James Dillon
Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML. Blood (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, Jamie Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Burnett, Charlotte Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood 143 (19) (2024)
Nicholas McCarthy, Gege Gui, Florent Dumezy, Christophe Roumier, Georgia Andrew, Sarah Green, Madeleine Jenkins, Alexandra C Adams, Naeem Khan, Charles F Craddock, Christopher S Hourigan, Adriana Plesa, Sylvie D Freeman
Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance. Leukemia 38 (8) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, Jamie Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Burnett, Charlotte Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood 143 (19) (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, Jamie Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Burnett, Charlotte Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood 143 (19) (2024)
Jad Othman, Nicola Potter, Adam Ivey, Yanis Tazi, Elli Papaemmanuil, Jelena Jovanovic, Sylvie D Freeman, Amanda Gilkes, Rosemary E Gale, Tanya Rapoz-D'Silva, Manohursingh Runglall, Michelle Kleeman, Pawan Dhami, Ian Thomas, Sean J Johnson, Joanna Canham, Jamie Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan Burnett, Charlotte Wilhelm-Benartzi, Brian James Patrick Huntly, Nigel H Russell, Richard Dillon
Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML. Blood 144 (7) (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Eduardo Rodríguez-Arbolí, Megan K D Othus, Sylvie D Freeman, Francesco Buccisano, Lok Lam Ngai, Ian Thomas, Raffaele Palmieri, Jacqueline Cloos, Sean Johnson, Elisa Meddi, Nigel H Russell, Adriano Venditti, Patrycja Gradowska, Gert J Ossenkoppele, Bob Löwenberg, Roland Bruno Walter
Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML). Leukemia (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Eduardo Rodríguez-Arbolí, Megan K D Othus, Sylvie D Freeman, Francesco Buccisano, Lok Lam Ngai, Ian Thomas, Raffaele Palmieri, Jacqueline Cloos, Sean Johnson, Elisa Meddi, Nigel H Russell, Adriano Venditti, Patrycja Gradowska, Gert J Ossenkoppele, Bob Löwenberg, Roland Bruno Walter
Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML). Leukemia (2024)
Nicholas McCarthy, Gege Gui, Florent Dumezy, Christophe Roumier, Georgia Andrew, Sarah Green, Madeleine Jenkins, Alexandra C Adams, Naeem Khan, Charles F Craddock, Christopher S Hourigan, Adriana Plesa, Sylvie D Freeman
Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance. Leukemia 38 (8) (2024)
Jad Othman, Nicola Potter, Adam Ivey, Jelena Jovanovic, Manohursingh Runglall, Sylvie D Freeman, Amanda Frances Gilkes, Ian Thomas, Sean J Johnson, Joanna Canham, James Durrell Cavenagh, Panagiotis Kottaridis, Claire Arnold, Hans Beier Ommen, Ulrik Malthe Overgaard, Mike Dennis, Alan K Burnett, Charlotte S Wilhelm-Benartzi, Richard Dilon, Nigel H Russell
Post induction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood (2024)
Nicholas McCarthy, Gege Gui, Florent Dumezy, Christophe Roumier, Georgia Andrew, Sarah Green, Madeleine Jenkins, Alexandra C Adams, Naeem Khan, Charles F Craddock, Christopher S Hourigan, Adriana Plesa, Sylvie D Freeman
Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance. Leukemia (2024)
Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman, Richard Dilon, Stephen Knapper, Leona M Batten, Joanna Canham, Emily L Hinson, Sophie Betteridge, Ulrik Malthe Overgaard, Amanda Gilkes, Nicola Potter, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie D Freeman, Mike Dennis, null null
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Sylvie D Freeman, Abin Thomas, Ian Thomas, Robert K Hills, Paresh Vyas, Amanda Frances Gilkes, Marlen Metzner, Niels Asger Jakobsen, Alison Kennedy, Amy Rachel Moore, Nuria Marquez-Almuina, Sarah Burns, Sophie King, Georgia Andrew, Kathleen M E Gallagher, Rob S Sellar, Paul A Cahalin, Duruta Weber, Mike Dennis, Priyanka Mehta, Stephen Knapper, Nigel H Russell
Fractionated Versus Single Dose Gemtuzumab Ozogamicin with Determinants of Benefit in Older AML: UK NCRI AML18 Trial. Blood (2023)
Peter Hokland, Isolda I Fernández, Sylvie D Freeman, Bjorn Tore Gjertsen, Jie Jin, Vidh Murthy, Masamitsu Yanada, Arnold Ganser
AML in the elderly-A global view. British journal of haematology (2023)
Jad Othman, Charlotte S Wilhelm-Benartzi, Richard Dilon, Stephen Knapper, Sylvie D Freeman, Leona M Batten, Joanna Canham, Emily L Hinson, Julie Wych, Sophie Betteridge, William Villiers, Michelle Kleeman, Amanda Frances Gilkes, Nicola Potter, Ulrik Overgaard, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Jane Hemmaway, Claire Arnold, Mike Dennis, Nigel H Russell
A Randomised Comparison of CPX-351 and FLAG-Ida in Adverse Karyotype AML and High-Risk MDS: The UK NCRI AML19 Trial. Blood advances (2023)
Justin Loke, Nicholas McCarthy, Aimee E Jackson, Shamyla Siddique, Andrea Hodgkinson, John Mason, Charles R Crawley, Maria Gilleece, Andrew J Peniket, Rachel Protheroe, Rahuman Salim, Eleni Tholouli, Keith M O Wilson, Georgia Andrew, Richard Dilon, Naeem Khan, Victoria Potter, Pramila Krishnamurthy, Charles Craddock, Sylvie D Freeman
Posttransplant MRD and T-cell chimerism status predict outcomes in patients allografted with AML/MDS. Blood advances (2023)
Jad Othman, Nicola Potter, Katya Mokretar, David Taussig, Anjum Khan, Pramila Krishnamurthy, Anne-Louise Latif, Paul Cahalin, James Aries, Mariam Amer, Edward Belsham, Eibhlin Conneally, Charles F Craddock, Dominic Culligan, Mike Dennis, Caroline Duncan, Sylvie D Freeman, Caroline Furness, Amanda Gilkes, Paraskevi Gkreka, Katherine Hodgson, Wendy Ingram, Manish Jain, Andrew King, Stephen Knapper, Panagiotis Kottaridis, Mary Frances Frances McMullin, Unmesh Mohite, Loretta Ngu, Jenny O'Nions, Katharine Patrick, Tom Rider, Wing Roberts, Marianne Tang Severinsen, Neill Storrar, Tom Taylor, Nigel H Russell, Richard Dilon
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML. Leukemia (2023)
Eduard Schulz, Peter D Aplan, Sylvie D Freeman, Steven Z Pavletic
Towards a Conceptualization of Measurable Residual Disease in Myelodysplastic Syndromes. Blood advances (2023)
Maximilian A Röhnert, Michael Kramer, Jonas Schadt, Philipp Ensel, Christian Thiede, Stefan W Krause, Veit L Bücklein, Jörg Hoffmann, Sonia Jaramillo, Richard F Schlenk, Christoph Röllig, Martin Bornhäuser, Nicholas McCarthy, Sylvie D Freeman, Uta Oelschlägel, Malte Bonin
Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia. Leukemia 36 (9) (2022)
Yanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, Elsa Bernard, Ian Thomas, Amanda Gilkes, Sylvie D Freeman, Yoann Pradat, Sean J Johnson, Robert Hills, Richard Dilon, Max Fine Levine, Daniel A Leongamornlert, Adam Butler, Arnold Ganser, Lars Bullinger, Konstanze Döhner, Oliver Ottmann, Richard A Adams, Hartmut Döhner, Peter J Campbell, Alan K Burnett, Michael Dennis, Nigel H Russell, Sean M Devlin, Brian James Patrick Huntly, Elli Papaemmanuil
Unified classification and risk-stratification in Acute Myeloid Leukemia. Nature communications 13 (1) (2022)
Priyanka Mehta, Nick Telford, Chris Wragg, Richard Dilon, Sylvie D Freeman, Damian Finnegan, Angela Hamblin, Mhairi Copland, Steve Knapper
A British Society for Haematology good practice paper: Recommendations for laboratory testing of UK patients with acute myeloid leukaemia. British journal of haematology (2022)
Nicholas James Short, Chenqi Fu, Donald A Berry, Roland Bruno Walter, Sylvie D Freeman, Christopher S Hourigan, Xuelin Huang, Graciela Nogueras Gonzalez, Hyunsoo Hwang, Xinyue Qi, Hagop M Kantarjian, Shouhao Zhou, Farhad Ravandi
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysis. Leukemia 36 (12) (2022)
Michael Heuser, Sylvie D Freeman, Gert J Ossenkoppele, Francesco Buccisano, Christopher S Hourigan, Lok Lam Ngai, Jesse Marc Tettero, Costa Bachas, Constance Baer, Marie Christine Bene, Veit L Bücklein, Anna Czyz, Barbara Denys, Richard Dilon, Michaela Feuring-Buske, Monica L Guzman, Torsten Haferlach, Lina Han, Julia K Herzig, Jeffrey L Jorgensen, Wolfgang Kern, Marina Y Konopleva, Francis Lacombe, Marta Libura, Agata Majchrzak, Luca Maurillo, Yishai Ofran, Jan Philippé, Adriana Plesa, Claude Preudhomme, Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A van de Loosdrecht, Bert A van der Reijden, Adriano Venditti, Agnieszka Świątek, Peter J M Valk, Brent L Wood, Roland Bruno Walter, Christian Thiede, Konstanze Döhner, Gail J Roboz, Jacqueline Cloos
2021 Update Measurable Residual Disease in Acute Myeloid Leukemia: European LeukemiaNet Working Party Consensus Document. Blood (2021)
Charles F Craddock, Aimee Jackson, Sylvie D Freeman
Reply to G. Gui et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (21) (2021)
Alan K Burnett, Nigel H Russell, Robert K Hills, Stephen Knapper, Sylvie D Freeman, Brian James Patrick Huntly, Richard E Clark, Ian F Thomas, Lars Kjeldsen, Mary Frances Frances McMullin, Mark Drummond, Jonathan Kell, Ruth Spearing
Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (8) (2020)
Diana Hanekamp, Alexander N Snel, Angèle Kelder, Willemijn J Scholten, Naeem Khan, Marlen Metzner, Maria Irno-Consalvo, Mayumi Sugita, Anja de Jong, Sjoerd Oude Alink, Harrie Eidhof, Miriam Wilhelm, Michaela Feuring-Buske, Jennichjen Slomp, Vincent H J van der Velden, Edwin Sonneveld, Monica Guzman, Gail J Roboz, Francesco Buccisano, Paresh Vyas, Sylvie D Freeman, Costa Bachas, Gert J Ossenkoppele, Gerrit J Schuurhuis, Jacqueline Cloos
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting. British journal of haematology 190 (6) (2020)
Charles F Craddock, Aimee Jackson, Justin Loke, Shamyla Siddique, Andrea Hodgkinson, John Mason, Georgia Andrew, Sandeep Nagra, Ram Malladi, Andrew Peniket, Maria H Gilleece, Rahuman Salim, Eleni Tholouli, Victoria Potter, Charles Crawley, Keith Wheatley, Rachel Protheroe, Paresh Vyas, Ann Hunter, Anne Parker, Keith Wilson, Jiří Pavlů, Jennifer L Byrne, Richard Dilon, Naeem Khan, Sylvie D Freeman, Sylvie D Freeman
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2020)
Sylvie D Freeman, Robert K Hills, Nigel H Russell, null null, Jacqueline Cloos, Angèle Kelder, Gert J Ossenkoppele, Gerrit J Schuurhuis, null null
Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults. British journal of haematology 186 (1) (2018)